| Prev Close: | 86.69 |
|---|---|
| Open: | 86.59 |
| Bid: | 87.47 x 100 |
| Ask: | 87.60 x 100 |
| 1y Target Est: | 93.56 |
| Beta: | 0.56 |
| Next Earnings Date: | 15-Oct-13 |
| Day's Range: | 86.26 - 87.49 |
|---|---|
| 52wk Range: | 67.80 - 94.42 |
| Volume: | 6,320,028 |
| Avg Vol (3m): | 8,747,910 |
| Market Cap: | 246.50B |
| P/E (ttm): | 19.42 |
| EPS (ttm): | 4.51 |
| Div & Yield: | 2.64 (3.00%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Private Equity's Newest Target: J&J?at Motley Fool(Tue 7:32PM EDT)
- Intel’s Huggers Said to Be Eyeing Hulu CEO Gig and 2 Other Dow Movers to Watchat Wall St. Cheat Sheet(Tue 6:43PM EDT)
- Final Glance: Medical Devices companiesAP(Tue 6:02PM EDT)
- Final Glance: Pharmaceuticals companiesAP(Tue 6:02PM EDT)
- Healthcare Stocks Up as Obamacare Takes HoldWyatt Investment Research(Tue 4:14PM EDT)
- GM’s Soft September, Walgreens Sales Surge, and 3 More Hot Stocksat Wall St. Cheat Sheet(Tue 2:40PM EDT)
- Why Lexicon Pharmaceuticals Inc. Shares Exploded Higherat Motley Fool(Tue 1:50PM EDT)
- Midday Glance: Pharmaceuticals companiesAP(Tue 1:22PM EDT)
- Midday Glance: Medical Devices companiesAP(Tue 1:22PM EDT)
- Health Care and Biotech ETFs Brace for Obamacareat Minyanville(Tue 1:00PM EDT)
- Who’s Bidding on Johnson & Johnson’s Blood Screening Unit?at Wall St. Cheat Sheet(Tue 12:37PM EDT)
- J&J Says Boehringer Doxil Dispute May Cause Shortageat Bloomberg(Tue 12:35PM EDT)
- Early Glance: Pharmaceuticals companiesAP(Tue 10:35AM EDT)
- Early Glance: Medical Devices companiesAP(Tue 10:35AM EDT)
- [video] Markets are up as government shuts downat CNBC(Tue 10:14AM EDT)
Press Releases
- Decision Diagnostics' Pharma Tech Division Schedules Large Order Shipments for Its Popular GenStrip Test StripMarketwired(Tue 9:25AM EDT)
- Johnson & Johnson to Host Conference Call on Third-Quarter ResultsPR Newswire(Tue, Sep 17)
- VisionCare Ophthalmic Technologies Secures Up To $15MM To Accelerate Growth Of Its Novel Treatment For Age-Related Macular DegenerationPR Newswire(Tue, Sep 17)
Reports
- JNJ: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(Oct 1)
- Thomson Reuters Stock Report - JOHNSON & JOHNSON (JNJ-N)Thomson Reuters Stock Report(Oct 1)
- Trading Report for (JNJ). A detailed report, including free correlated market...Stock Traders Daily(Oct 1)